Combination therapy for the treatment of cancer

Details for Australian Patent Application No. 2009316853 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Graff, Jeremy Richard

Agent FB Rice

Pub. Number AU-A-2009316853

PCT Pub. Number WO2010/059575

Priority 61/116,910 21.11.08 US

Filing date 17 November 2009

Wipo publication date 27 May 2010

International Classifications

A61K 31/282 (2006.01)

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/7125 (2006.01) - Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 June 2011 PCT application entered the National Phase

  PCT publication WO2010/059575 Priority application(s): WO2010/059575

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009316867-Fixation plate for use in the Lapidus approach

2009316845-Braking system for front caster wheels of a self-propelled vehicle